Trial Site Detail
Drug: |
Dasatinib (BMS-354825) |
|||
|---|---|---|---|---|
Trial: |
Study of BMS-354825 in Patients With Solid Tumors |
|||
| Conditions: | Tumors | |||
Trial Status: |
Completed |
|||
Site name unknown, Koto-Ku, 135-0063 |
Principal Investigator: |
Taku Seriu, MD, PhD |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Site name unknown, Koto-Ku, 135-0063 Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.